Supernus Pharmaceuticals reported $141.33M in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 10223M 233M
Adamas Pharmaceuticals ADMS:US 21.97M 2.66M
Aerie Pharmaceuticals AERI:US $ 27.18M 4.22M
Ani Pharmaceuticals ANIP:US $ 48.62M 5.9M
Aphria Inc APH:CN C$ 153.64M 6.89M
Aurora Cannabis Inc ACB:CN 55.16M 12.51M
Bristol Myers Squibb BMY:US $ 11703M 630M
Canopy Growth Corp WEED:CN C$ 136.21M 12.23M
Cara Therapeutics CARA:US $ 0 1.93M
Corcept Therapeutics CORT:US $ 91.59M 12.15M
Eisai 4523:JP Y 198894M 51284M
Eli Lilly And LLY:US $ 6740.1M 65.5M
Endo International Ordinary Shares ENDP:US $ 713.83M 4.09M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Horizon Pharma HZNP:US $ 832.55M 490.14M
JAZZ PHA JAZZ:US $ 751.81M 144.23M
Lannett LCI:US $ 106.01M 6.36M
Marinus Pharmaceuticals MRNS:US 1.9M 99K
Pacira Pharmaceuticals PCRX:US $ 135.59M 16.56M
Perrigo Ordinary Shares PRGO:US $ 981.1M 28.9M
Pfizer PFE:US $ 18977M 4395M
Revance Therapeutics RVNC:US $ 18.8M 5.5M
Supernus Pharmaceuticals SUPN:US $ 141.33M 10.4M
Teva Pharmaceutical Industries TEVA:US $ 3910M 72M
United Therapeutics UTHR:US $ 446.5M 67.4M
Xeris Pharmaceuticals Inc XERS:US $ 8.91M 711K